Skip to main content
SpringerLink
Log in

Staphylococcus aureus endocarditis in the 21st century

  • Clinical Trials Review
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lichtman SS: Treatment of subacute bacterial endocarditis: current results. Ann Intern Med 1943, 19:878–892.

    Google Scholar 

  2. Hricak V, Matejicka F, Sedlak T, et al.: Native valve staphylococcal endocarditis: etiology, risk factors and outcome in 53 cases. J Chemother 1998, 10(5):360–368.

    PubMed  CAS  Google Scholar 

  3. Roder BL, Wandall DA, Frimodt-Moller N, et al.: Clinical features of Staphylococcus aureus endocarditis. Arch Intern Med 1999, 159:462–469.

    Article  PubMed  CAS  Google Scholar 

  4. Fowler VG Jr., Sanders LL, Kong LK, et al.: Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999, 28:106–114.

    PubMed  Google Scholar 

  5. Rosen AB, Fowler VG Jr., Corey GR, et al.: Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 1999, 130:810–820.

    PubMed  CAS  Google Scholar 

  6. Jernigan JA: Glycopeptide resistance in Staphylococcus aureus. Curr Infect Dis Rep 1999, 1:317–318.

    PubMed  Google Scholar 

  7. Cohen MA, Huband MD: Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Diagn Microbiol Infect Dis 1999, 33(1):43–46.

    Article  PubMed  CAS  Google Scholar 

  8. Raad I, Bompart F, Hachem R: Prospective, randomized dose-ranging open phase II pilot study of quinupristin/ dalfopristin versus vancomycin in the treatment of catheterrelated staphylococcal bacteremia. Eur J Clin Microbiol Infect Dis 1999, 18(3):199–202.

    Article  PubMed  CAS  Google Scholar 

  9. Patel R, Rouse MS, Piper KE, Steckelberg JM: In vitro activity of linezolid against vancomycin-resistant Enterococci, methicillin-resistant Staphylococcus aureus and penicillinresistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1999, 34(2):119–122.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Medical College of Pennsylvania/Hahnemann University, 3300 Henry Avenue, 19129, Philadelphia, PA, USA

    Oksana M. Korzeniowski MD

Authors
  1. Oksana M. Korzeniowski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korzeniowski, O.M. Staphylococcus aureus endocarditis in the 21st century. Curr Infect Dis Rep 2, 279–280 (2000). https://doi.org/10.1007/s11908-000-0004-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-000-0004-1

Keywords

Search

Navigation